MedCity News October 13, 2020
The companies made their first cross-sale to Guidewell Health, the parent company of Florida Blue. Livongo’s diabetes platform will become available to 50,000 of the insurer’s members.
When Teladoc first announced plans for its $18.5 billion merger with Livongo, the two companies touted the potential for pairing telehealth with a platform to manage chronic conditions. Now, the duo have made their first combined sale to insurer Florida Blue’s parent company GuideWell Health, they announced on Monday at HLTH.
“There’s a lot of takers. There’s a lot of interest,” Livongo CEO Glen Tullman said, noting there had been an uptick in activity since the two companies announced their merger.
Florida Blue already offered Teladoc’s services to its members, and Livongo had...
Today's Sponsors
Today's Sponsor